Senior involvement in every decision.

No. The intention to sell may arise from a received proposal, a succession issue, the need for liquidity, the departure of a partner, founder fatigue or a change in the sector. These events make the decision relevant, but they do not automatically determine the answer. Before structuring a sell-side process, we help the business owner understand whether the most appropriate path is a full sale, a partial sale, bringing in an investor, raising debt, reorganizing the partnership, preparing the company, waiting or not transacting. A proposal is not just a price. It is the beginning of a decision.

Yes. Fundraising is part of our corporate finance work and may involve debt, equity, investor entry, a strategic partner, partial sale or combined structures. The work, however, does not begin by sending materials to potential funders. First, we evaluate the purpose of the funds, the required amount, the company's financial capacity, the impact on control, the corporate structure, acceptable risk, the growth horizon and the compatibility between capital and strategy. After that definition, we structure the thesis, prepare the company and access suitable sources of capital. Capital is not just funding. It is a decision about risk, control and growth.

Because an operation can be technically well executed and still represent the wrong decision. Without a prior architecture stage, the process may begin with unclear objectives, misaligned partners, fragile value expectations, an unprepared company, premature exposure, incomplete criteria, an inadequate choice of structure and counterparties without fit. The A.R.C.O.S Method organizes context, objectives, alternatives, value, readiness, stakeholders, risks and consequences before turning the situation into a mandate. Executing the wrong alternative with excellence remains a strategic failure.

This question should not be answered solely by the existence of a proposal, the desire for liquidity or the perception that the market is hot. Decision Architecture considers what triggered the reflection, the partners' objectives, value expectations, the company's readiness, the sector's moment, the risks of acting and the cost of waiting. In some cases, selling may be the appropriate path. In others, preparing the company for a defined period may strengthen value and negotiation power. Waiting can also be a strategic decision, provided there are criteria, milestones and conditions to revisit it. Waiting without criteria is postponement. Preparing with purpose is part of the decision.

The choice does not depend only on how much capital the company needs. Each alternative changes control, governance, financial risk, future participation, speed of growth, payment capacity, partner autonomy and exit horizon in different ways. Debt can preserve ownership but increase financial pressure. Equity reduces the need for immediate payment but shares control and future value. A partial sale can generate liquidity and bring in a new partner. A strategic partner can offer, in addition to capital, market access, technology, distribution or operational capability. The A.R.C.O.S Method organizes these impacts before starting a fundraising process or looking for investors. The best capital structure is not only the one that brings resources. It is the one that sustains the future the partners want to build.

Price is an essential criterion, but it should not be analyzed in isolation. A proposal must also be evaluated by payment form and term, conditions precedent, guarantees and holdbacks, earn-out, closing risk, future governance, partner continuity, preservation of key people, brand continuity and compatibility between the parties. A nominally higher offer may carry greater uncertainty, more restrictive conditions or consequences incompatible with the owner's objectives. For this reason, Decision Architecture defines in advance the criteria by which proposals will be compared. The best outcome is not necessarily the highest offer. It is the proposal that best fulfills the objectives that originated the decision.

Prime HN's work covers company preparation, valuation, value thesis construction, mapping and approach of buyers or investors, negotiation, due diligence support and coordination through closing. The difference lies in the starting point. Before mobilizing the market, we apply the A.R.C.O.S Method to understand the moment, evaluate alternatives, define criteria and verify whether the company is prepared for the path being considered. We do end-to-end M&A. But we do not start with the market. We start with the decision that will justify access to the market.

The market should be accessed when there is sufficient clarity about the chosen path, the objectives of the operation, the counterparty profile, the value thesis, the company's readiness, negotiation criteria, information that can be disclosed and the confidentiality protocol. This preparation reduces indiscriminate exposure and increases the quality of conversations. Prime HN does not treat access as distributing materials to a long list. We map and prioritize counterparties by strategic fit, financial capacity, timing, reputation and real execution possibility. A network without criteria is a list. Strategic access is a methodology.

ARCOS does not replace these capabilities. It determines how and when they should be applied. Valuation helps understand value, scenarios and sensitivities. Fundraising connects the company to suitable sources of capital. M&A transforms a decision into preparation, access, negotiation, due diligence and closing. The A.R.C.O.S Method integrates these capabilities into five movements: Architect → Reinforce → Connect → Orchestrate → Sustain. Thus, valuation, fundraising and M&A stop being isolated services and begin to respond to a structured decision. Valuation informs the decision. M&A and fundraising execute the chosen path.

The method may confirm that the company is ready for a sale, acquisition, fundraising or investor entry. It may also indicate that, before moving forward, it is necessary to organize information, strengthen controls, reduce dependencies, align partners, prepare succession, revisit value expectations, improve results or define milestones for a future decision. In certain situations, the recommendation may be to wait or not transact. This does not weaken Prime HN's transactional capability. On the contrary, it shows that M&A and fundraising are consequences of a decision - not answers automatically applied to any situation. Our role is not to take every company to market. It is to build the right decision and, when there is a path, execute it with rigor.